| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
1
| 2
| 3
| 4
| 5
| 6
| 7
|
NEXT 
|
| Title |
Date |
Price |
|
The increasing importance of biotechnology and its application in the development of new medicines has driven the industry forward in 2000. However, 2000 was a tough year for the smaller companies that... |
Jan, 2001 |
€1 605 |
|
This market brief looks at the evolving computer and IT systems that are being applied to drug discovery to speed time to market. How can you benefit from this report? * Assess the impact of IT developments... |
Jan, 2001 |
€2 033 |
|
Scientific and Medical Journals on the Web has evolved since 1998. Originally, it addressed whether or not Scientific, Technical and Medical (STM) publishers needed to have an online version of their journal,... |
Mar, 2005 |
€1 926 |
|
Sales reps are a vital part of a life science supplier's success because they provide a direct link to their customers. Based on a 34-question survey of over 1,800 scientists, the second edition of Improving... |
Jan, 2005 |
€2 033 |
|
The GPC Biotech AG Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The GTC Biotherapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The GTX INC/TN Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The GW Pharmaceuticals PLC Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The H.Lundbeck AS Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Halozyme Therapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The HealthWatch Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
The Helix BioMedix Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The HemaCare Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Oct, 2006 |
€375 |
|
The Hemagen Diagnostics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Mar, 2006 |
€375 |
|
As a country, India offers some significant competitive advantages in the area of Biotechnology such as low-cost technology in clinical trials, R&D, molecule synthesis and fine chemical production. The... |
Jan, 2001 |
€139 |
|
The Hemispherx Biopharma Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Hemosol Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Heska Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Hi-Tech Pharmacal Co Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Hollis-Eden Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Jan, 2007 |
€375 |
|
|
|
|
